Companies / haichen-pharma-300584

Haichen Pharma (300584)

ChinaTechnology & Electronics

Overview

Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates. The company's products include landiolol hydrochloride, rivaroxaban, tigecycline, torasemide, cefuroxime sodium, ceftriaxone hydrochloride, ganciclovir sodium, adenosine monophosphate, and adenosine monophosphate for injection; voglibose tablets, lansoprazole enteric-coated tablets, amlodipine besylate tablets, and g

Employees553
Market Cap$3.9B
Revenue$688.7M
Listed OnShenzhen Stock Exchange
Ticker300584
CEOMr. Yuping Cao
HeadquartersNanjing

Website

https://www.hicin.cn